Literature DB >> 12391153

Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D.

Marc Schmidt1, Silvia Fernandez de Mattos, Armando van der Horst, Rob Klompmaker, Geert J P L Kops, Eric W-F Lam, Boudewijn M T Burgering, René H Medema.   

Abstract

The FoxO forkhead transcription factors FoxO4 (AFX), FoxO3a (FKHR.L1), and FoxO1a (FKHR) represent important physiological targets of phosphatidylinositol-3 kinase (PI3K)/protein kinase B (PKB) signaling. Overexpression or conditional activation of FoxO factors is able to antagonize many responses to constitutive PI3K/PKB activation including its effect on cellular proliferation. It was previously shown that the FoxO-induced cell cycle arrest is partially mediated by enhanced transcription and protein expression of the cyclin-dependent kinase inhibitor p27(kip1) (R. H. Medema, G. J. Kops, J. L. Bos, and B. M. Burgering, Nature 404:782-787, 2000). Here we have identified a p27(kip1)-independent mechanism that plays an important role in the antiproliferative effect of FoxO factors. Forced expression or conditional activation of FoxO factors leads to reduced protein expression of the D-type cyclins D1 and D2 and is associated with an impaired capacity of CDK4 to phosphorylate and inactivate the S-phase repressor pRb. Downregulation of D-type cyclins involves a transcriptional repression mechanism and does not require p27(kip1) function. Ectopic expression of cyclin D1 can partially overcome FoxO factor-induced cell cycle arrest, demonstrating that downregulation of D-type cyclins represents a physiologically relevant mechanism of FoxO-induced cell cycle inhibition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391153      PMCID: PMC134724          DOI: 10.1128/MCB.22.22.7842-7852.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

Review 1.  The multiple roles of PTEN in tumor suppression.

Authors:  A Di Cristofano; P P Pandolfi
Journal:  Cell       Date:  2000-02-18       Impact factor: 41.582

2.  Unified nomenclature for the winged helix/forkhead transcription factors.

Authors:  K H Kaestner; W Knochel; D E Martinez
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

Review 3.  The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling.

Authors:  F Vazquez; W R Sellers
Journal:  Biochim Biophys Acta       Date:  2000-02-14

4.  AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1.

Authors:  R H Medema; G J Kops; J L Bos; B M Burgering
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

5.  Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN.

Authors:  N Nakamura; S Ramaswamy; F Vazquez; S Signoretti; M Loda; W R Sellers
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 6.  Genetic pathways that regulate ageing in model organisms.

Authors:  L Guarente; C Kenyon
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

Review 7.  Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle.

Authors:  S V Ekholm; S I Reed
Journal:  Curr Opin Cell Biol       Date:  2000-12       Impact factor: 8.382

Review 8.  The Rb/E2F pathway: expanding roles and emerging paradigms.

Authors:  J W Harbour; D C Dean
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

9.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

10.  BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

Authors:  A L Shaffer; X Yu; Y He; J Boldrick; E P Chan; L M Staudt
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

View more
  192 in total

Review 1.  Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation.

Authors:  G V Baracho; A V Miletic; S A Omori; M H Cato; R C Rickert
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

2.  FoxO3a changes in pyramidal neurons and expresses in non-pyramidal neurons and astrocytes in the gerbil hippocampal CA1 region after transient cerebral ischemia.

Authors:  Ki-Yeon Yoo; Seung-Hae Kwon; Choong Hyun Lee; Bingchun Yan; Joon Ha Park; Ji Hyeon Ahn; Jung Hoon Choi; Taek Geun Ohk; Jun Hwi Cho; Moo-Ho Won
Journal:  Neurochem Res       Date:  2011-11-12       Impact factor: 3.996

3.  Regulation of microtubule, apoptosis, and cell cycle-related genes by taxotere in prostate cancer cells analyzed by microarray.

Authors:  Yiwei Li; Xingli Li; Maha Hussain; Fazlul H Sarkar
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

4.  Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins.

Authors:  Caroline Bouchard; Judith Marquardt; Alexandra Brás; René H Medema; Martin Eilers
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

5.  RhoE inhibits cell cycle progression and Ras-induced transformation.

Authors:  Priam Villalonga; Rosa M Guasch; Kirsi Riento; Anne J Ridley
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

6.  Regulation of cell cycle progression by forkhead transcription factor FOXO3 through its binding partner DNA replication factor Cdt1.

Authors:  Yiru Zhang; Yuqian Xing; Lei Zhang; Yang Mei; Kazuo Yamamoto; Tak W Mak; Han You
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

7.  Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1.

Authors:  Huarui Lu; Ping Liu; Yunqian Pan; Haojie Huang
Journal:  Neoplasia       Date:  2011-09       Impact factor: 5.715

Review 8.  Quiescent T cells and HIV: an unresolved relationship.

Authors:  Dimitrios N Vatakis; Christopher C Nixon; Jerome A Zack
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

Review 9.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

Review 10.  FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis.

Authors:  Zainab Jagani; Amrik Singh; Roya Khosravi-Far
Journal:  Biochim Biophys Acta       Date:  2007-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.